Fidelity Investments
GNOM icon

Fidelity Investments’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Fidelity Investments’s Portfolio GNOM Stock Details GNOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-47
Closed -$1.82K – 5461
2024
Q4 		$1.82K Buy
+47
New +$1.98K ﹤0.01% 4835
2022
Q1 		– Hold
0
– – – 5178
2021
Q4 		– Hold
0
– – – 4586

Other funds holding GNOM

OCM
One Capital Management Westlake Village, California $3.6B AUM 16.02% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $1.05B AUM 18.22% 1-Year Est. Return
FTUS
Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Mirae Asset Global ETFs Holdings
Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $83.9B AUM 60.43% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
IWM
IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Fidelity Investments's GNOM Position: Q1 2025 in Review

Fidelity Investments sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2025, closing a stake of 47 shares — an estimated $1.82K sold.

Fidelity Investments first reported a position in GNOM in Q4 2024 and held it in 1 quarter. The position peaked at $1.82K in Q4 2024. 60 funds tracked by Wall St. Rank hold GNOM as of Q1 2025.

  • Fidelity Investments reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2025 after selling out during the quarter.
  • Fidelity Investments sold 47 Global X Genomics & Biotechnology ETF shares in Q1 2025, an estimated $1.82K.
  • Fidelity Investments first reported a position in Global X Genomics & Biotechnology ETF in Q4 2024 and held it in 1 quarter.
  • Fidelity Investments's Global X Genomics & Biotechnology ETF position peaked at $1.82K in Q4 2024.
  • 60 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2025.

Based on Fidelity Investments's 13F filing for Q1 2025, filed 12 May 2025.